Author:
Talluri M.V.N. Kumar,Khatoon Lubna,Kalariya Pradipbhai D.,Chavan Balasaheb B.,Ragampeta Srinivas
Publisher
Oxford University Press (OUP)
Subject
General Medicine,Analytical Chemistry
Reference28 articles.
1. Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients
2. Linking diabetic complications to sorbitol oxidation, oxidative stress and metabolic suppression;Joseph;Journal of Diabetes & Metabolism,2012
3. Pharmacological Properties of Fidarestat, a Potent Aldose Reductase Inhibitor, Clarified by Using Sorbitol in Human and Rat Erythrocytes
4. Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis;Drel;International Journal of Molecular Medicine,2008
5. Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献